ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
1-Year Return 36.49%
This Quarter Return
-9.36%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$37.1M
AUM Growth
-$21.3M
Cap. Flow
-$8.76M
Cap. Flow %
-23.61%
Top 10 Hldgs %
93.85%
Holding
15
New
1
Increased
3
Reduced
7
Closed
2

Top Buys

1
ZYME icon
Zymeworks
ZYME
+$1.01M
2
DTIL icon
Precision BioSciences
DTIL
+$905K
3
PTGX icon
Protagonist Therapeutics
PTGX
+$247K
4
ARVN icon
Arvinas
ARVN
+$225K

Top Sells

1
BPMC
Blueprint Medicines
BPMC
+$4.04M
2
SLN
Silence Therapeutics
SLN
+$2.53M
3
ARWR icon
Arrowhead Research
ARWR
+$2.01M
4
KYMR icon
Kymera Therapeutics
KYMR
+$1.23M
5
RGNX icon
Regenxbio
RGNX
+$536K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BPMC
1
DELISTED
Blueprint Medicines
BPMC
$7.43M 13.32%
83,926
-45,674
-35% -$4.04M
ARWR icon
2
Arrowhead Research
ARWR
$3.78B
$7.01M 12.57%
550,130
-157,459
-22% -$2.01M
PTGX icon
3
Protagonist Therapeutics
PTGX
$3.42B
$3.95M 7.08%
81,692
+5,100
+7% +$247K
KYMR icon
4
Kymera Therapeutics
KYMR
$3.11B
$3.79M 6.8%
138,521
-45,000
-25% -$1.23M
DTIL icon
5
Precision BioSciences
DTIL
$58.3M
$3.46M 6.21%
726,149
+189,773
+35% +$905K
ARVN icon
6
Arvinas
ARVN
$576M
$2.53M 4.54%
360,766
+32,000
+10% +$225K
RGNX icon
7
Regenxbio
RGNX
$477M
$1.94M 3.48%
271,302
-75,000
-22% -$536K
ACET icon
8
Adicet Bio
ACET
$62.5M
$1.85M 3.32%
2,456,194
-75,000
-3% -$56.6K
BCYC
9
Bicycle Therapeutics
BCYC
$482M
$1.46M 2.61%
171,695
-50,216
-23% -$426K
IMTX icon
10
Immatics
IMTX
$697M
$1.38M 2.47%
304,902
-69,000
-18% -$311K
RPTX icon
11
Repare Therapeutics
RPTX
$73.5M
$1.28M 2.29%
1,293,715
– –
ZYME icon
12
Zymeworks
ZYME
$1.15B
$1.01M 1.8%
+84,482
New +$1.01M
AMGN icon
13
Amgen
AMGN
$150B
– –
0
– –
SLN
14
Silence Therapeutics
SLN
$250M
– –
-367,214
Closed -$2.53M
STRO icon
15
Sutro Biopharma
STRO
$81.6M
– –
-498
Closed -$916